Literature DB >> 13678727

Loop-cone cerclage in pregnancy: a 5-year review.

Terry S Dunn1, Valerie Ginsburg, Doug Wolf.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the efficacy and outcomes of patients undergoing conization utilizing a technique of loop-cone cerclage when a diagnostic cone biopsy was required in pregnancy.
METHODS: All loop conizations between 1997 and 2001 were reviewed; 15 patients were identified who underwent cone- cerclage with 13 medical records completely available for review. Abstracted data included age, parity, pap smears prior to and during pregnancy, and histology obtained during colposcopy. The operative time for the procedure, estimated blood loss, complications, pathology of loop specimen, and pregnancy outcomes were recorded.
RESULTS: Thirteen charts were available for complete review. The mean operating time was 22 min; 11 patients had less than 50 cc blood loss and two patients had a 250 cc blood loss. The median age was 26.5, average parity was 2, and mean gestational age was 24.1 weeks. Six patients had abnormal pap smears prior to pregnancy, one woman had previously undergone colposcopy, and there was no documentation of previous pap smears in six patients. During pregnancy, on pap smear, nine patients had HSIL, three patients had ASCUS/LSIL, and one patient had adenocarcinoma. Thirteen patients underwent colposcopy and biopsy; eight patients had the question of invasive disease, five patients had endocervical glandular involvement with carcinoma in situ, which were the indications for conization. There were no intraoperative or late postoperative complications. All patients delivered at term.
CONCLUSIONS: While the need for conization during pregnancy is rare, there are indications when it is necessary. Loop-cone cerclage is a safe method for performing diagnostic and therapeutic conization during pregnancy.

Entities:  

Mesh:

Year:  2003        PMID: 13678727     DOI: 10.1016/s0090-8258(03)00395-0

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

Authors:  Sileny N Han; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

2.  Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature.

Authors:  Francesco Sopracordevole; Diego Rossi; Jacopo Di Giuseppe; Marta Angelini; Pierino Boschian-Bailo; Monica Buttignol; Andrea Ciavattini
Journal:  Case Rep Obstet Gynecol       Date:  2014-03-16

Review 3.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.